Skip to content

DBV.FR

DBV Technologies SA

Healthcare · Biotechnology · FR

—
Ask drillr

Income statement

MetricTTM2025202420232022
Revenue
Total Revenue———15.7M4.8M
Cost of Revenue——6.8M——
Gross Profit——(6.8M)15.7M4.8M
Operating Expenses
R&D Expense144.5M116.7M89.9M60.2M75.5M
SG&A Expense60.6M36.0M23.8M31.9M25.9M
General & Admin Expense55.1M32.8M23.8M29.5M24.3M
Selling & Marketing Expense5.5M3.2M—2.4M1.6M
Other Expenses3.9M(5.6M)—(1.0K)—
Total Operating Expenses209.1M147.1M113.7M92.2M101.5M
Cost and Expenses209.1M147.1M120.5M92.2M101.5M
Operating Income (EBIT)(209.1M)(147.1M)(120.5M)(76.4M)(96.6M)
Non-Operating
Interest Income1.5M601.0K2.7M3.7M427.0K
Interest Expense—————
Net Interest Income1.5M601.0K2.7M3.7M427.0K
Other Non-Op Income/Expense1.7M600.0K2.7M3.7M427.0K
Non-Operating Income (excl Interest)(3.0K)(1.0K)(2.7M)1.0K—
EBT (Pre-Tax Income)(207.4M)(146.5M)(117.8M)(72.7M)(96.2M)
Income Tax Expense(26.0K)491.0K(4.1M)7.0K70.0K
Bottom Line
Net Income(207.3M)(146.9M)(113.7M)(72.7M)(96.3M)
Earnings from Cont. Ops(207.3M)(146.9M)(113.7M)(72.7M)(96.3M)
Earnings from Discont. Ops—————
Bottom Line Net Income(207.3M)(146.9M)(113.7M)(72.7M)(96.3M)
Per Share
Basic EPS($2.34)($1.70)($1.20)($0.75)($1.25)
Diluted EPS($2.34)($1.70)($1.20)($0.75)($1.25)
Revenue Per Share$0.00$0.00$0.00$0.17$0.06
Shares
Basic Shares Outstanding90.2M86.4M96.2M95.1M77.4M
Diluted Shares Outstanding90.2M86.4M96.2M95.1M77.4M
Profitability Metrics
EBITDA(198.2M)(143.9M)(111.0M)(63.3M)(83.5M)
D&A10.9M3.2M6.8M13.2M13.2M
EBIT(209.0M)(147.1M)(117.8M)(76.4M)(96.6M)

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Sep 1, 2026